These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17436010)

  • 1. Donor B cells in splenic follicles of experimental pulmonary allograft recipients.
    Grau V; Fuchs-Moll G; Krasteva G; Hirschburger M; Steiniger B; Padberg W
    Langenbecks Arch Surg; 2008 Mar; 393(2):219-26. PubMed ID: 17436010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells.
    Okuda T; Ishikawa T; Azhipa O; Ichikawa N; Demetris AJ; Starzl TE; Murase N
    Transplantation; 2002 Jul; 74(1):103-11. PubMed ID: 12134107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor leukocyte migration following extremity transplantation in an experimental model.
    Hoffman LA; Codner MA; Shuster BA; Bogossian N; Egozi L; Harper AD; Steinman RM; LaTrenta GS; Shires GT
    Plast Reconstr Surg; 1992 Dec; 90(6):999-1006; discussion 1007-8. PubMed ID: 1360166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
    Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
    Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of rat cytomegalovirus in lung allografts: an experimental and immunohistochemical study in rats.
    Yagyu K; Steinhoff G; Duijvestijn AM; Bruggeman CA; Matsumoto H; van Breda Vriesman PJ
    J Heart Lung Transplant; 1992; 11(6):1031-40. PubMed ID: 1333797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney.
    Penfield JG; Wang Y; Li S; Kielar MA; Sicher SC; Jeyarajah DR; Lu CY
    Kidney Int; 1999 Nov; 56(5):1759-69. PubMed ID: 10571784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Local Intrapulmonary Production of Antibodies Specific to Donor Major Histocompatibility Complex Class I With the Progression of Chronic Rejection of Lung Allografts.
    Miyamoto E; Motoyama H; Sato M; Aoyama A; Menju T; Shikuma K; Sowa T; Yoshizawa A; Saito M; Takahagi A; Tanaka S; Takahashi M; Ohata K; Kondo T; Hijiya K; Chen-Yoshikawa TF; Date H
    Transplantation; 2017 May; 101(5):e156-e165. PubMed ID: 28207638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation.
    Sekine Y; Bowen LK; Heidler KM; Van Rooijen N; Brown JW; Cummings OW; Wilkes DS
    J Immunol; 1997 Oct; 159(8):4084-93. PubMed ID: 9378999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential splenic migration of dendritic cells after immunologic unresponsiveness in rat hepatic allografts induced by pretransplant donor-specific transfusion.
    Ohshiro H; Yamaguchi Y; Okabe K; Takai E; Goto M; Zhang JL; Uchino S; Yamada S; Ishihara K; Furuhashi T; Mori K; Ikeda S; Sera Y; Ogawa M
    J Surg Res; 2001 Nov; 101(1):29-36. PubMed ID: 11676551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol.
    Shimizu A; Yamada K; Sachs DH; Colvin RB
    Kidney Int; 2000 Dec; 58(6):2546-58. PubMed ID: 11115090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
    Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
    Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of donor apoptotic versus necrotic splenocytes on splenic allograft tolerance.
    Jiang H; Lu Z; Pan S; Sun B; Meng F; Tan H; Meng Q; Sun X
    J Surg Res; 2006 Dec; 136(2):247-54. PubMed ID: 17056068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with keratinocyte growth factor does not improve lung allograft survival in the rat.
    Hirschburger M; Obert M; Traupe H; Kuchenbuch T; Padberg W; Fehrenbach H; Grau V
    Langenbecks Arch Surg; 2009 Jan; 394(1):133-41. PubMed ID: 18283483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.